Financhill
Sell
26

SCKT Quote, Financials, Valuation and Earnings

Last price:
$1.31
Seasonality move :
19.83%
Day range:
$1.26 - $1.36
52-week range:
$0.91 - $1.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.54x
P/B ratio:
0.55x
Volume:
7.9K
Avg. volume:
31.9K
1-year change:
11.49%
Market cap:
$10M
Revenue:
$17M
EPS (TTM):
-$0.22
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $19.3M $15.7M $23.2M $21.2M $17M
Revenue Growth (YoY) 17.01% -18.46% 47.76% -8.45% -19.8%
 
Cost of Revenues $9.2M $7.4M $10.8M $10.9M $8.6M
Gross Profit $10.1M $8.3M $12.4M $10.4M $8.5M
Gross Profit Margin 52.46% 53.09% 53.61% 48.81% 49.68%
 
R&D Expenses $3.9M $3.1M $4M $4.4M $4.8M
Selling, General & Admin $5.6M $5.1M $5.8M $6.5M $6.8M
Other Inc / (Exp) -- -$3.3M $65.1K -- --
Operating Expenses $9.5M $8.3M $9.7M $10.8M $11.6M
Operating Income $606.4K $76.4K $2.7M -$446K -$3.1M
 
Net Interest Expenses $100.7K $97.5K $198.9K $175K $242.2K
EBT. Incl. Unusual Items $505.7K -$3.3M $2.6M -$621.1K -$3.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $219.1K -$50.8K -$1.9M -$708K -$1.4M
Net Income to Company $286.6K -$3.3M $4.5M $86.9K -$1.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $286.6K -$3.3M $4.5M $86.9K -$1.9M
 
Basic EPS (Cont. Ops) $0.05 -$0.51 $0.58 $0.01 -$0.27
Diluted EPS (Cont. Ops) $0.05 -$0.51 $0.48 $0.01 -$0.27
Weighted Average Basic Share $6M $6M $7M $7.2M $7.2M
Weighted Average Diluted Share $6.2M $6M $8.9M $7.5M $7.2M
 
EBITDA $1.1M -$2.6M $3.9M $833.3K -$1.7M
EBIT $606.4K -$3.2M $2.8M -$446K -$3.1M
 
Revenue (Reported) $19.3M $15.7M $23.2M $21.2M $17M
Operating Income (Reported) $606.4K $76.4K $2.7M -$446K -$3.1M
Operating Income (Adjusted) $606.4K -$3.2M $2.8M -$446K -$3.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4.1M $6.3M $3.7M $3.2M $3.9M
Revenue Growth (YoY) -17.5% 53.8% -41.01% -14% 20.79%
 
Cost of Revenues $1.8M $2.9M $2.1M $1.8M $2M
Gross Profit $2.3M $3.4M $1.7M $1.4M $1.9M
Gross Profit Margin 55.33% 54.17% 44.39% 44.24% 48.99%
 
R&D Expenses $680.8K $1M $1.1M $1.2M $1.2M
Selling, General & Admin $1.1M $1.5M $1.5M $1.6M $1.8M
Other Inc / (Exp) -$4.4M -- -- -- --
Operating Expenses $1.8M $2.5M $2.6M $2.8M $2.9M
Operating Income $448.9K $953.8K -$947.4K -$1.4M -$1M
 
Net Interest Expenses $23.9K $50.1K $43.1K $76.4K $84.2K
EBT. Incl. Unusual Items -$4M $903.6K -$990.5K -$1.5M -$1.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $800 $260K -$116.5K -$150K --
Net Income to Company -$4M $643.6K -$874K -$1.3M -$1.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4M $643.6K -$874K -$1.3M -$1.1M
 
Basic EPS (Cont. Ops) -$0.62 $0.08 -$0.11 -$0.18 -$0.15
Diluted EPS (Cont. Ops) -$0.62 $0.07 -$0.11 -$0.18 -$0.15
Weighted Average Basic Share $6M $7.2M $7.2M $7.3M $7.6M
Weighted Average Diluted Share $6M $8.9M $7.2M $7.3M $7.6M
 
EBITDA -$3.8M $1.2M -$664.3K -$1M -$631.8K
EBIT -$4M $953.8K -$947.4K -$1.4M -$1M
 
Revenue (Reported) $4.1M $6.3M $3.7M $3.2M $3.9M
Operating Income (Reported) $448.9K $953.8K -$947.4K -$1.4M -$1M
Operating Income (Adjusted) -$4M $953.8K -$947.4K -$1.4M -$1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $15.6M $21.7M $22.2M $17.8M $18.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7.3M $10M $11.2M $9.1M $9M
Gross Profit $8.3M $11.7M $11M $8.7M $9.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $3.4M $3.6M $4.3M $4.7M $4.8M
Selling, General & Admin $5.1M $5.6M $6.3M $6.8M $7M
Other Inc / (Exp) -$4.4M $1.1M $55K -- --
Operating Expenses $8.5M $9.2M $10.6M $11.5M $11.8M
Operating Income -$239.8K $2.5M $392.8K -$2.8M -$2.5M
 
Net Interest Expenses $68.8K $196.3K $182.4K $211.1K $301.3K
EBT. Incl. Unusual Items -$4.7M $3.4M $265.5K -$3M -$2.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $134.9K -$1.7M -$299K -$692K -$1.5M
Net Income to Company -$4.8M $5.1M $564.5K -$2.3M -$1.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.8M $5.1M $564.5K -$2.3M -$1.4M
 
Basic EPS (Cont. Ops) -$0.75 $0.71 $0.07 -$0.30 -$0.19
Diluted EPS (Cont. Ops) -$0.75 $0.60 $0.05 -$0.30 -$0.22
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$4M $4.3M $2M -$1.5M -$993.1K
EBIT -$4.6M $3.6M $447.8K -$2.8M -$2.5M
 
Revenue (Reported) $15.6M $21.7M $22.2M $17.8M $18.3M
Operating Income (Reported) -$239.8K $2.5M $392.8K -$2.8M -$2.5M
Operating Income (Adjusted) -$4.6M $3.6M $447.8K -$2.8M -$2.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $11M $17.1M $16.1M $12.6M $13.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.2M $7.8M $8.2M $6.5M $6.9M
Gross Profit $5.9M $9.3M $7.8M $6.1M $7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.4M $2.9M $3.3M $3.6M $3.6M
Selling, General & Admin $3.9M $4.3M $4.8M $5.1M $5.4M
Other Inc / (Exp) -$4.4M $10.1K -- -- --
Operating Expenses $6.3M $7.2M $8.1M $8.8M $9M
Operating Income -$451.8K $2M -$294.5K -$2.6M -$2.1M
 
Net Interest Expenses $51.5K $150.2K $133.7K $169.7K $228.9K
EBT. Incl. Unusual Items -$4.9M $1.9M -$428.1K -$2.8M -$2.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $800 -$1.6M $0 $16K --
Net Income to Company -$4.9M $3.5M -$428.1K -$2.8M -$2.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.9M $3.5M -$428.1K -$2.8M -$2.3M
 
Basic EPS (Cont. Ops) -$0.76 $0.45 -$0.06 -$0.36 -$0.30
Diluted EPS (Cont. Ops) -$0.76 $0.37 -$0.06 -$0.36 -$0.30
Weighted Average Basic Share $18.1M $20.8M $21.6M $21.6M $22.6M
Weighted Average Diluted Share $18.1M $25.2M $22.5M $21.6M $22.6M
 
EBITDA -$4.4M $2.6M $680.1K -$1.6M -$888.5K
EBIT -$4.8M $2M -$294.5K -$2.6M -$2.1M
 
Revenue (Reported) $11M $17.1M $16.1M $12.6M $13.9M
Operating Income (Reported) -$451.8K $2M -$294.5K -$2.6M -$2.1M
Operating Income (Adjusted) -$4.8M $2M -$294.5K -$2.6M -$2.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $958.9K $2.1M $6.1M $3.6M $2.8M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.8M $2.1M $2.6M $2.7M $1.7M
Inventory $3.2M $3.2M $5.2M $5.6M $5.4M
Prepaid Expenses $228.4K $259.8K $333.6K $529.9K $365.1K
Other Current Assets $83.8K $75.6K $61.6K $87.3K $75.6K
Total Current Assets $7.5M $7.9M $14.4M $12.8M $10.7M
 
Property Plant And Equipment $1.8M $1.5M $1.3M $5.2M $6.1M
Long-Term Investments -- -- -- -- --
Goodwill $4.4M -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $202.6K $159K $140.3K $250.2K $249.7K
Total Assets $19.5M $15.6M $25.6M $28.6M $28.7M
 
Accounts Payable $2.1M $1.4M $2.2M $1.7M $1.6M
Accrued Expenses $566.4K $375.5K $693K $742.5K $580K
Current Portion Of Long-Term Debt -- $1.4M $1.8M $1.5M $3M
Current Portion Of Capital Lease Obligations $427.6K $483.3K $258.1K $444.5K $483.2K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $5.5M $4.1M $5.4M $5M $6.5M
 
Long-Term Debt -- -- $125K -- --
Capital Leases -- -- -- -- --
Total Liabilities $6.2M $4.4M $5.5M $8.3M $9.3M
 
Common Stock $6K $6.1K $7.2K $7.1K $7.3K
Other Common Equity Adj -- -- -- -- --
Common Equity $13.2M $11.2M $20M $20.3M $19.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $13.2M $11.2M $20M $20.3M $19.4M
 
Total Liabilities and Equity $19.5M $15.6M $25.6M $28.6M $28.7M
Cash and Short Terms $958.9K $2.1M $6.1M $3.6M $2.8M
Total Debt $1.7M $1.4M $2M $1.5M $3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.8M $5.4M $4.2M $3.1M $2.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.4M $2.7M $1.8M $1.6M $1.4M
Inventory $3.4M $4.4M $6.1M $5.5M $5.3M
Prepaid Expenses -- -- -- -- --
Other Current Assets $317K $601.4K $576.2K $617.3K $471.8K
Total Current Assets $8M $13.2M $13M $11M $10.3M
 
Property Plant And Equipment $1.5M $1.3M $5.2M $5.8M $5.6M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- $1.8M -- -- $1.5M
Other Long-Term Assets $169.9K $151.2K $311.7K $250.7K $248.7K
Total Assets $15.2M $23.6M $28.2M $27.3M $27.7M
 
Accounts Payable $2M $1.7M $1.7M $1.3M $1.4M
Accrued Expenses $402.2K $702.9K $761.5K $642.3K $758K
Current Portion Of Long-Term Debt $2.1M $1.8M $1.6M $3M $4M
Current Portion Of Capital Lease Obligations $471K $384.2K $434.5K $474K $516.6K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $5.6M $5.1M $5.1M $6M $7.3M
 
Long-Term Debt $375.9K $250K -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $6.4M $5.3M $8.5M $8.9M $9.8M
 
Common Stock $6.1K $7.2K $7.1K $7.3K $7.6K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $8.8M $18.3M $19.7M $18.4M $18M
 
Total Liabilities and Equity $15.2M $23.6M $28.2M $27.3M $27.7M
Cash and Short Terms $1.8M $5.4M $4.2M $3.1M $2.9M
Total Debt $2.5M $2.1M $1.6M $3M $4M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $286.6K -$3.3M $4.5M $86.9K -$1.9M
Depreciation & Amoritzation $462.9K $596.9K $1.2M $1.3M $1.4M
Stock-Based Compensation $519.9K $507.1K $693.4K $998.7K $1.2M
Change in Accounts Receivable -$469.8K $724.5K -$463.7K -$83.6K $960.2K
Change in Inventories -$906.6K -$16.9K -$2M -$447.2K $192.6K
Cash From Operations $873.5K $804.5K $2.1M -$111.4K $48.6K
 
Capital Expenditures $603K $536.5K $691.8K $1.2M $2.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$603K -$536.5K -$691.8K -$1.2M -$2.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $17.4M $8.3M $1M -- $1.6M
Long-Term Debt Repaid -$17.8M -$7.5M -$375K -$500K -$125K
Repurchase of Common Stock -- -$8.5K -$2.9K -$829.6K -$351.8K
Other Financing Activities -- -- -- -- --
Cash From Financing -$396.7K $894.9K $2.5M -$1.2M $1.3M
 
Beginning Cash (CF) $1.1M $958.9K $2.1M $6.1M $3.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$126.1K $1.2M $4M -$2.5M -$796.8K
Ending Cash (CF) $958.9K $2.1M $6.1M $3.6M $2.8M
 
Levered Free Cash Flow $270.6K $268K $1.5M -$1.3M -$2.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$4M $643.6K -$874K -$1.3M -$1.1M
Depreciation & Amoritzation $146.5K $203.1K $283.2K $371.6K $399.5K
Stock-Based Compensation $129.6K $183.9K $260.4K $278.3K $250.8K
Change in Accounts Receivable -$589.3K -$234.9K $1.6M $1.6M $1.1M
Change in Inventories -$108.6K -$415K -$262.4K -$20K -$64.4K
Cash From Operations $142.4K $732.6K -$629K $5.7K $204K
 
Capital Expenditures $118.4K $258.3K $350.5K $365.6K $396.6K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$118.4K -$258.3K -$350.5K -$365.6K -$396.6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.4M -- -- -- $989.1K
Long-Term Debt Repaid -$1.7M -$125K -$125K -- --
Repurchase of Common Stock -- -- -$275.7K -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $823.8K -$41.5K -$371.3K $22.5K $989.1K
 
Beginning Cash (CF) $927K $4.9M $5.6M $3.4M $2.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $847.9K $432.8K -$1.4M -$337.5K $796.4K
Ending Cash (CF) $1.8M $5.4M $4.2M $3.1M $2.9M
 
Levered Free Cash Flow $24K $474.3K -$979.5K -$360K -$192.6K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$4.8M $5.1M $564.5K -$2.3M -$1.4M
Depreciation & Amoritzation $566.4K $715.8K $1.6M $1.3M $1.5M
Stock-Based Compensation $520.9K $618.7K $924.1K $1.1M $1.1M
Change in Accounts Receivable $702.8K -$343.7K $890.9K $252.5K $118.4K
Change in Inventories -$834.1K -$1.1M -$1.7M $620.8K $278.7K
Cash From Operations $753.1K $1.6M $931.1K -$603.8K $136.6K
 
Capital Expenditures $540.4K $724.9K $1M $1.7M $1.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$540.4K -$724.9K -$1M -$1.7M -$1.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $12.7M $997.2K -- -- --
Long-Term Debt Repaid -$12.1M -$250K -$500K -$250K --
Repurchase of Common Stock -$8K -- -$655.4K -$384.3K -$143.4K
Other Financing Activities -- -- -- -- --
Cash From Financing $681K $2.7M -$1M $1.2M $869.4K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $893.7K $3.6M -$1.1M -$1.1M -$180.2K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $212.7K $875.9K -$108.4K -$2.3M -$1.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$4.9M $3.5M -$428.1K -$2.8M -$2.3M
Depreciation & Amoritzation $437K $555.9K $974.5K $1M $1.2M
Stock-Based Compensation $393K $504.7K $735.4K $880.5K $798.2K
Change in Accounts Receivable $477.6K -$590.6K $764.1K $1.1M $258.4K
Change in Inventories -$183.4K -$1.2M -$995.4K $72.6K $158.6K
Cash From Operations $386.7K $1.2M -$30.2K -$522.5K -$434.5K
 
Capital Expenditures $374.6K $562.9K $910.6K $1.5M $564.4K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$374.5K -$562.9K -$910.6K -$1.5M -$491.6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $8.3M $1M -- $1.6M $989.1K
Long-Term Debt Repaid -$7.5M -$250K -$375K -$125K --
Repurchase of Common Stock -$8K -$1.2K -$653.7K -$208.4K --
Other Financing Activities -- -- -- -- --
Cash From Financing $803.8K $2.6M -$917.8K $1.5M $1M
 
Beginning Cash (CF) $3M $12M $17.1M $10M $7.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $816K $3.2M -$1.9M -$529.9K $86.7K
Ending Cash (CF) $3.8M $15.2M $15.2M $9.5M $7.8M
 
Levered Free Cash Flow $12.2K $620.2K -$940.8K -$2M -$998.8K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock